Consumer satisfaction with involvement in drug research: a social validity study

Area of Science:

• Pediatric pharmacology
• Clinical trial research
• Child psychology and psychiatry

Background:

• Drug research involving children with intellectual disabilities is crucial for advancing treatment options.
• Assessing the perceived value and satisfaction of participating families is essential for ethical research conduct.

Purpose of the Study:

• To evaluate the social importance and personal benefits experienced by families participating in pediatric drug research.
• To understand parental perspectives on the acceptability and outcomes of drug studies involving children with intellectual disabilities.

Main Methods:

• A survey was administered to parents of children with mental retardation or borderline IQ after their participation in two drug studies.
• The questionnaire focused on the acceptability of study procedures and satisfaction with treatment outcomes, termed 'social validity'.

Main Results:

• 63.5% of families responded to the survey, with 83% reporting satisfactory answers about medication roles and 88% satisfied with pharmacotherapy conclusions.
• Nearly all parents deemed study assessments important, and 88% would participate again, indicating high perceived value.

Conclusions:

• Families perceived drug research participation as practically beneficial and generally had positive experiences.
• Further research is needed to assess consumer reactions to a wider range of research involving vulnerable populations.